Hartford Healthcare F (HGHFX)
Fund Assets | 769.28M |
Expense Ratio | 0.92% |
Min. Investment | $0.00 |
Turnover | 40.00% |
Dividend (ttm) | 2.11 |
Dividend Yield | 5.30% |
Dividend Growth | n/a |
Payout Frequency | Annual |
Ex-Dividend Date | Dec 27, 2024 |
Previous Close | 40.44 |
YTD Return | 3.61% |
1-Year Return | -7.82% |
5-Year Return | 11.13% |
52-Week Low | 34.64 |
52-Week High | 46.04 |
Beta (5Y) | n/a |
Holdings | 81 |
Inception Date | Feb 28, 2017 |
About HGHFX
The Hartford Healthcare Fund Class F is an open-end mutual fund focused on delivering long-term capital appreciation by investing primarily in the global healthcare sector. Managed by an experienced team from Wellington Management, the fund allocates at least 80% of its assets to equity securities of companies engaged in healthcare-related industries, encompassing pharmaceuticals, biotechnology, medical technology, healthcare services, and emerging healthcare subsectors. The portfolio is broadly diversified, typically holding around 100 stocks, with substantial exposure to large-cap healthcare firms while also investing in mid- and small-cap companies to capture sector innovation and growth opportunities. Notable portfolio holdings include leading names such as Eli Lilly & Co., UnitedHealth Group, and Merck & Co. The fund emphasizes U.S. equities but also maintains exposure to international healthcare companies, reflecting the sector’s global scope. With annual operating expenses around 0.91% and an active share of approximately 44%, the Hartford Healthcare Fund Class F plays a significant role for investors seeking targeted exposure to healthcare markets, leveraging sector expertise and active management to capitalize on trends and advancements within the industry.
Performance
HGHFX had a total return of -7.82% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.00%.
Top 10 Holdings
47.73% of assetsName | Symbol | Weight |
---|---|---|
Eli Lilly and Company | LLY | 12.37% |
UnitedHealth Group Incorporated | UNH | 5.67% |
Boston Scientific Corporation | BSX | 4.62% |
Johnson & Johnson | JNJ | 4.47% |
Merck & Co., Inc. | MRK | 4.12% |
AbbVie Inc. | ABBV | 3.84% |
Intuitive Surgical, Inc. | ISRG | 3.57% |
Vertex Pharmaceuticals Incorporated | VRTX | 3.20% |
Danaher Corporation | DHR | 3.05% |
Cencora, Inc. | COR | 2.83% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
Dec 27, 2024 | $0.2154 | Dec 30, 2024 |
Dec 11, 2024 | $1.89862 | Dec 12, 2024 |
Dec 12, 2022 | $0.36137 | Dec 13, 2022 |
Dec 10, 2021 | $4.37361 | Dec 13, 2021 |
Dec 10, 2020 | $5.16605 | Dec 11, 2020 |
Dec 10, 2019 | $2.36232 | Dec 11, 2019 |